Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity in patients with idiopathic pulmonary fibrosis (IPF)

Authors :: Carlos Alberto de Castro Pereira
Dominique Valeyre
David J. Lederer
C Albera
Steven D. Nathan
Lisa Lancaster
I Glaspole
Jeffrey J. Swigris
Marilyn K. Glassberg
Paul W. Noble
Williamson Z. Bradford
Elizabeth A. Fagan
Z Lin
Ulrich Costabel
Te King
Source :: Pneumologie. 70
Publication Year :: 2016
Publisher :: Georg Thieme Verlag KG, 2016.

Subjects :: Pulmonary and Respiratory Medicine
Idiopathic pulmonary fibrosis
medicine.medical_specialty
business.industry
Internal medicine
medicine
Percent Predicted Forced Vital Capacity
In patient
Pirfenidone
medicine.disease
business
Surgery
medicine.drug

Full Text Access

Tools